Holen Sie sich die Stockscreener-App
737.00
4.87%
34.25
Handel nachbörslich:
738.85
1.85
+0.25%
Regeneron Pharmaceuticals Inc Aktie (REGN) Neueste Nachrichten
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
FDA Approves Aflibercept Injection for Macular Edema Following Retinal Vein Occlusion - Drug Topics
Novartis, Moderna detail manufacturing expansions in the US, among others - Endpoints News
Regeneron wins 2 Eylea nods, ramping up competition with Roche - Fierce Pharma
Regeneron Wins FDA Nod For Eylea HD With Reduced Injection Schedule For Patients With Vision Loss - Benzinga
With new approvals, Regeneron’s higher-dose Eylea gets more competitive - BioPharma Dive
Wells Fargo Raises Price Target for REGN to $700 | REGN Stock News - GuruFocus
EC approval for Libtayo as adjuvant treatment of high-risk CSCC - The Pharma Letter
Seizert Capital Partners LLC Has $45.14 Million Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
FDA Hands Regeneron Two Eylea HD Nods in One Day - BioSpace
Bernstein reiterates Outperform rating on Regeneron stock at $818 - Investing.com India
Regeneron’s Eylea franchise boosted by pair of FDA approvals - Yahoo Finance
United States AMD Drug Market 2025: Get Exclusive Data | Top 5 - openPR.com
Intrust Bank NA Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Raymond James Adjusts PT on Regeneron Pharmaceuticals to $800 From $723, Keeps Outperform Rating - MarketScreener
Nomura Asset Management Co. Ltd. Trims Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Why Regeneron Pharmaceuticals Inc. (RGO) stock is favored by hedge fundsProfit Target & Weekly Momentum Stock Picks - newser.com
Rockefeller Capital Management L.P. Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Meridian Wealth Management LLC Lowers Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Stocks to Watch Thursday: Walmart, Nvidia, Cracker Barrel, Regeneron - The Wall Street Journal
How strong is Regeneron Pharmaceuticals Inc. stock balance sheetTreasury Yields & Daily Market Momentum Tracking - newser.com
Why analysts raise outlook for Regeneron Pharmaceuticals Inc. (RGO) stockQuarterly Profit Review & Capital Efficiency Focused Strategies - newser.com
How Regeneron Pharmaceuticals Inc. (RGO) stock responds to job market shiftsMarket Volume Report & Advanced Swing Trade Entry Plans - newser.com
Stocks to Watch : Nvidia, Kulicke & Soffa, Regeneron - MarketScreener
Regeneron (REGN) Gains FDA Approval for Eylea HD Injection - GuruFocus
Regeneron Announces Plans To Establish New Drug Manufacturing Facility In Saratoga Springs NY - Pharmaceutical Online
Regeneron Gets FDA Approval for Eylea to Treat Macular Edema - MarketScreener
Regeneron gets FDA nod for Eylea in macular edema treatment - Seeking Alpha
FDA Approves Eylea HD Injection from Regeneron (REGN) for Eye Conditions - GuruFocus
FDA approves EYLEA HD for retinal vein occlusion with extended dosing - Investing.com Canada
Regeneron stock rises as EYLEA HD gets FDA approval for new indication - Investing.com Canada
Regeneron Announces FDA Approval of EYLEA HD® for Retinal Vein Occlusion with New Dosing Options - Quiver Quantitative
Regeneron (NASDAQ: REGN) secures FDA approval for EYLEA HD in RVO with 8-week option and monthly dosing - Stock Titan
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected - simplywall.st
What does recent volatility data suggest for Regeneron Pharmaceuticals Inc.IPO Watch & Risk Managed Investment Signals - newser.com
How currency fluctuations impact Regeneron Pharmaceuticals Inc. stockMarket Volume Summary & Reliable Momentum Entry Alerts - newser.com
Regeneron to Invest More Than $2 Billion to Double Pharmaceutical Manufacturing Capacity in New York State - Design and Development Today
Can Regeneron Pharmaceuticals Inc. stock hit record highs again2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Regeneron (REGN) Gains EU Approval for Expanded Use of Libtayo - GuruFocus
Can a trend reversal in Regeneron Pharmaceuticals Inc. lead to recoveryWeekly Investment Summary & Low Volatility Stock Recommendations - newser.com
Regeneron gets EU nod for expanded approval of Libtayo (REGN:NASDAQ) - Seeking Alpha
Regeneron Pharmaceuticals Gets European Commission's Approval for Expanded Indication for Libtayo - MarketScreener
European Commission Approves the Pd-1 Inhibitor Libtayo of Regeneron Pharmaceuticals, Inc - MarketScreener
REGN: European Approval for Regeneron's Libtayo in Skin Cancer T - GuruFocus
Regeneron (REGN) EC Approves Libtayo as First Adjuvant CSCC Immunotherapy, 68% Risk Cut - Stock Titan
How Regeneron Pharmaceuticals Inc. stock responds to policy changesMarket Volume Summary & Weekly High Conviction Ideas - newser.com
United States Bispecific T-cell Engagers (BiTEs) Market Size, - openPR.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Raiffeisen Bank International AG - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by ARS Investment Partners LLC - MarketBeat
Can Regeneron Pharmaceuticals Inc. stock weather global recessionStop Loss & Growth Focused Investment Plans - newser.com
Why Regeneron Pharmaceuticals Inc. (RGO) stock is listed among top recommendationsJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Citigroup Inc. - MarketBeat
Stocks Flashing Renewed Technical Strength: Regeneron Pharmaceuticals - Investor's Business Daily
3.25%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):